Patel, D. (2024) “Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in Treatment of Patients With Polycystic Ovary Syndrome: A Systemic Review of Metabolic and Cardiovascular Outcomes”, Journal For International Medical Graduates, 3(1). doi:10.56570/jimgs.v1i1.149.